InsidersTradesSigma
基于 3 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Discover the detailed record of transactions filed by 김이랑, 管理人员. Director active across 2 companies, notably 온코크로스. Cumulatively, 14 reports have been logged. Regulator: DART (FSS). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
14 条申报中的 14 条
Kim I-rang is an executive at Oncocross, a company specializing in oncology treatments. He plays a key role in managing operations and the company's strategy, contributing to its development in the market. His expertise is essential for product innovation.